Hofseth Biocare
Hofseth Biocare ASA, commonly referred to as Hofseth Biocare, is a leading player in the biotechnology and health supplement industry, headquartered in Norway. Founded in 2009, the company has established itself as a pioneer in the development of high-quality marine ingredients, focusing on sustainable practices and innovative extraction methods. With operations primarily in Norway and a growing presence in international markets, Hofseth Biocare offers a range of unique products, including omega-3 fatty acids, collagen peptides, and other bioactive compounds derived from fish. Their commitment to sustainability and quality has positioned them as a trusted supplier in the health and wellness sector, earning recognition for their advanced research and development initiatives. As a result, Hofseth Biocare continues to make significant strides in promoting health through marine biotechnology.
DitchCarbon Score
How does Hofseth Biocare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hofseth Biocare's score of 30 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hofseth Biocare's reported carbon emissions
In 2024, Hofseth Biocare reported total carbon emissions of approximately 14,930,000 kg CO2e. This figure includes 48,000 kg CO2e from Scope 2 emissions, while Scope 3 emissions accounted for significant contributions: 6,000 kg CO2e from purchased goods and services, 445,000 kg CO2e from upstream transportation and distribution, and 1,453,000 kg CO2e from downstream transportation and distribution. In 2023, the company recorded Scope 2 emissions of about 46,000 kg CO2e, while in 2022, Scope 2 emissions remained consistent at approximately 48,000 kg CO2e. The data for 2021 indicated Scope 1 emissions of 1,810,000 kg CO2e and Scope 2 emissions of 45,000 kg CO2e, while 2020 figures showed Scope 1 emissions at 1,619,000 kg CO2e and Scope 2 emissions at 90,400 kg CO2e. Hofseth Biocare has not set specific reduction targets or initiatives as part of the Science Based Targets initiative (SBTi) or other climate pledges. The emissions data is not cascaded from any parent organization, indicating that the figures are solely attributed to Hofseth Biocare ASA. The company continues to monitor and report its emissions, contributing to transparency in its climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 1,619,000 | 0,000,000 | - | - | - |
| Scope 2 | 90,400 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 3 | - | - | - | - | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hofseth Biocare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
